John Militello, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 855 shares at $3.61 ($3K) on 2026-05-13, disclosed to the SEC on 2026-05-14.
Seasonal sale ($3k) by See Remarks — this insider has traded RCKT in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RCKT | SELL | 2026-02-18 | $12K | — | Filing → |
| RCKT | SELL | 2025-11-20 | $3K | — | Filing → |
| RCKT | SELL | 2025-10-16 | $193K | — | Filing → |